GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » International Stem Cell Corp (OTCPK:ISCO) » Definitions » E10

International Stem Cell (International Stem Cell) E10 : $-2.78 (As of Mar. 2024)


View and export this data going back to 2006. Start your Free Trial

What is International Stem Cell E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

International Stem Cell's adjusted earnings per share data for the three months ended in Mar. 2024 was $-0.030. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is $-2.78 for the trailing ten years ended in Mar. 2024.

During the past 3 years, the average E10 Growth Rate was 28.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of International Stem Cell was 28.70% per year. The lowest was 15.10% per year. And the median was 26.60% per year.

As of today (2024-05-22), International Stem Cell's current stock price is $0.109. International Stem Cell's E10 for the quarter that ended in Mar. 2024 was $-2.78. International Stem Cell's Shiller PE Ratio of today is .


International Stem Cell E10 Historical Data

The historical data trend for International Stem Cell's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

International Stem Cell E10 Chart

International Stem Cell Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only -12.50 -8.11 -6.60 - -2.94

International Stem Cell Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -4.35 -3.97 -3.37 -2.94 -2.78

Competitive Comparison of International Stem Cell's E10

For the Biotechnology subindustry, International Stem Cell's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


International Stem Cell's Shiller PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, International Stem Cell's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where International Stem Cell's Shiller PE Ratio falls into.



International Stem Cell E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, International Stem Cell's adjusted earnings per share data for the three months ended in Mar. 2024 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=-0.03/131.7762*131.7762
=-0.030

Current CPI (Mar. 2024) = 131.7762.

International Stem Cell Quarterly Data

per share eps CPI Adj_EPS
201406 -3.885 100.560 -5.091
201409 -1.400 100.428 -1.837
201412 -3.810 99.070 -5.068
201503 -1.070 99.621 -1.415
201506 -0.520 100.684 -0.681
201509 -0.280 100.392 -0.368
201512 -0.720 99.792 -0.951
201603 -5.190 100.470 -6.807
201606 0.260 101.688 0.337
201609 -0.300 101.861 -0.388
201612 0.547 101.863 0.708
201703 -0.780 102.862 -0.999
201706 -0.250 103.349 -0.319
201709 -0.540 104.136 -0.683
201712 -0.290 104.011 -0.367
201803 -0.140 105.290 -0.175
201806 -0.060 106.317 -0.074
201809 0.020 106.507 0.025
201812 -0.150 105.998 -0.186
201903 -0.120 107.251 -0.147
201906 -0.090 108.070 -0.110
201909 0.000 108.329 0.000
201912 -0.360 108.420 -0.438
202003 -0.050 108.902 -0.061
202006 -0.140 108.767 -0.170
202009 -0.070 109.815 -0.084
202012 -0.090 109.897 -0.108
202103 -0.080 111.754 -0.094
202106 0.030 114.631 0.034
202109 -0.020 115.734 -0.023
202112 -0.040 117.630 -0.045
202203 -0.001 121.301 -0.001
202206 0.000 125.017 0.000
202209 -0.040 125.227 -0.042
202212 0.000 125.222 0.000
202303 -0.004 127.348 -0.004
202306 0.030 128.729 0.031
202309 -0.020 129.860 -0.020
202312 -0.040 129.419 -0.041
202403 -0.030 131.776 -0.030

Add all the adjusted EPS together and divide 10 will get our e10.


International Stem Cell  (OTCPK:ISCO) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


International Stem Cell E10 Related Terms

Thank you for viewing the detailed overview of International Stem Cell's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


International Stem Cell (International Stem Cell) Business Description

Traded in Other Exchanges
N/A
Address
9745 Businesspark Avenue, San Diego, CA, USA, 92131
International Stem Cell Corp is a clinical-stage biotechnology company. It is focused on therapeutic and biomedical product development with multiple long-term therapeutic opportunities. The company develops different cell types from its stem cells that may result in therapeutic products. The clinical applications of the company include neural stem cells for the treatment of Parkinson's disease and other central nervous system disorders; Liver cells, which are used to treat a variety of congenital and acquired liver diseases; and retinal cells and three-dimensional eye structures. It operates in three segments, the therapeutic market, the biomedical market, and the anti-aging market. The Biomedical products business segment accounts for the majority of revenue.
Executives
Paul V Maier director 3595 JOHN HOPKINS COURT, SAN DIEGO CA 92121
Andrei Semechkin 10 percent owner 1 OVERLOOK DR. UNIT 11, AMHERST NH 03031
Sofya Bakalova officer: Dir. of Legal Affairs & Oper. 5950 PRIESTLY DRIVE, CARLSBAD CA 92008
Wright Don director 2829 RUCKER AVE, 3RD FLOOR, EVERETT WA 98201
Jennifer Stephens officer: Acting Chief Financial Officer 5950 PRIESTLY DRIVE, CARLSBAD CA 92008
Mahnaz Ebrahimi officer: Chief Financial Officer 5950 PRIESTLY DRIVE, CARLSBAD CA 92008
Rouslan Semechkin director, 10 percent owner 2595 JASON CT, OCEANSIDE CA 92056
Tibor Jay Novak officer: Interim CFO 5950 PRIESTLY DRIVE, CARLSBAD CA 92008
John Simon Craw officer: Executive Vice President 5950 PRIESTLY DRIVE, CARLSBAD CA 92008
James H Berglund director C/O INTERNATIONAL STEM CELL CORPORATION, 5950 PRIESTLY DRIVE, CARLSBAD CA 92008
Ar Partners Llc 10 percent owner 5950 PRIESTLY DR., CARLSBAD CA 92008
Kurt Andrew May officer: President and COO 5950 PRIESTLY DRIVE, CARLSBAD CA 92008
Linh T Nguyen officer: Chief Financial Officer 5950 PRIESTLY DR., CARLSBAD CA 92008
Jeffrey Janus director, officer: President 2595 JASON COURT, OCEANSIDE CA 92056
Charles J Casamento director 99 BELBROOK WAY, ATHERTON CA 94027